UBS AG (UBS) Analysts Upgrade Biogen Idec (BIIB) Shares to "Buy" - LocalizedUSA

UBS AG (UBS) Analysts Upgrade Biogen Idec (BIIB) Shares to "Buy" LocalizedUSA The Company's products address diseases, such As multiple sclerosis (MS), non-Hodgkin's lymphoma (NHL), rheumatoid arthritis (RA), Crohn's disease (CD) and psoriasis . In addition to the marketed products, Biogen Idec has a number of wares candidates ... UBS Bullish on Biogen Idec (BIIB), Says Buy Financial tidings Network Online all vii news articles » Link To Article